IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion

J Immunol. 2009 Nov 15;183(10):6639-45. doi: 10.4049/jimmunol.0902587. Epub 2009 Oct 28.

Abstract

We determined whether human NK cells could contribute to immune defenses against Mycobacterium tuberculosis through production of IL-22. CD3(-)CD56(+) NK cells produced IL-22 when exposed to autologous monocytes and gamma-irradiated M. tuberculosis, and this depended on the presence of IL-15 and IL-23, but not IL-12 or IL-18. IL-15-stimulated NK cells expressed 10.6 times more DAP10 mRNA compared with control NK cells, and DAP10 siRNA inhibited IL-15-mediated IL-22 production by NK cells. Soluble factors produced by IL-15-activated NK cells inhibited growth of M. tuberculosis in macrophages, and this effect was reversed by anti-IL-22. Addition of rIL-22 to infected macrophages enhanced phagolysosomal fusion and reduced growth of M. tuberculosis. We conclude that NK cells can contribute to immune defenses against M. tuberculosis through production of IL-22, which inhibits intracellular mycobacterial growth by enhancing phagolysosomal fusion. IL-15 and DAP-10 elicit IL-22 production by NK cells in response to M. tuberculosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interleukin-12 / pharmacology
  • Interleukin-15 / pharmacology
  • Interleukin-18 / pharmacology
  • Interleukin-22
  • Interleukin-23 / pharmacology
  • Interleukins / immunology*
  • Interleukins / metabolism
  • Interleukins / pharmacology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / metabolism
  • Killer Cells, Natural / microbiology
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Macrophages / metabolism
  • Macrophages / microbiology
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / growth & development
  • Mycobacterium tuberculosis / immunology*
  • Phagosomes / drug effects
  • Phagosomes / immunology*
  • Phagosomes / metabolism
  • Phagosomes / microbiology
  • RNA, Messenger / agonists
  • RNA, Messenger / immunology
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / immunology
  • RNA, Small Interfering / metabolism
  • Receptors, Immunologic / agonists
  • Receptors, Immunologic / genetics
  • Receptors, Immunologic / immunology
  • Receptors, Immunologic / metabolism
  • Recombinant Proteins / pharmacology
  • Tuberculosis / immunology*
  • Tuberculosis / microbiology

Substances

  • HCST protein, human
  • Interleukin-15
  • Interleukin-18
  • Interleukin-23
  • Interleukins
  • RNA, Messenger
  • RNA, Small Interfering
  • Receptors, Immunologic
  • Recombinant Proteins
  • Interleukin-12